2 Manhattanville Road
Purchase , NY 10577
Purchase , NY 10577
News
-
Teladoc Health dropped 22% to $15.98 after the online health service provider reported weaker-than-expected quarterly revenue.
Revenue in the fourth quarter increased 4% to $660.5 million from $637.7 million, net loss shrank to $28.9 million from $3.8 billion, and diluted loss per share fell to 17 cents from $23.49 a year ago.
Results for the fourth quarter of 2022 primarily included non-cash goodwill impairment charges of $3.77 billion, or $23.26 per share, stock-based compensation expense of $50.8 million, or $0.31 per share, and amortiz More
Feb 21, 2024 -
Teladoc Health Inc soared 25.5% to $28.60 after the online healthcare provider reported better-than-expected quarterly results.
Revenue in the second quarter increased 10% to $652.4 million and net loss shrank to $65 million from $3.1 billion and diluted loss per share fell to 40 cents from $19.22 a year ago.
The prior year's quarter included a non-cash goodwill charge of $3.03 billion or $18.78 a share.
The company guided revenue in the third quarter between $650 million and $675 million and net loss per share between 50 cents and 40 cen More
Jul 26, 2023
Executive/
Director
Links
Price
- Last Close
-
$ 10.8
$ -0.23 -2.13 %
Dec 5, 2024
- 52-Week High/Low
- $22.97 - $6.85
- YTD
- -49.9%
- Trading Volume
- 179,867
- Market Cap Full
- $ 1.8B
- Shares Outstanding
-
165.6M
Oct 24, 2023
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | -46.6% | 51.5% | 15.6% | 12.2% | -5% | -7.9% | -21.4% | 9.5% | -30.1% |
| Q2 | - | 66.9% | 38.8% | 50.8% | 22.8% | 4% | -8.5% | -54% | -2.2% | -3.5% |
| Q3 | -21.8% | 14.3% | -4.5% | 45.4% | -0.4% | 8% | -22.8% | -23.7% | -26.6% | - |
| Q4 | -19.4% | -9.9% | 1.9% | -40.8% | 23.8% | -10% | -28.5% | -6.7% | 16.9% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -9.9% | -22.4% | -0.1% | -4.9% | - | - | - | - | - | - | - | - |
| 2023 | 24.4% | -9.9% | -2.3% | 2.5% | -12.8% | 9.4% | 17.6% | -23.9% | -18% | -11% | 9.7% | 18.7% |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | -8% | 111% | 42% | 68% | 137% | -53% | -74% | -9% | -50% |
Earnings
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 0.40 | 0.30 | -0.39 | -0.43 | - | - | - | -0.42 |
| Q2 | 0.46 | 0.38 | 0.28 | -0.4 | 0.41 | - | - | - | -0.40 |
| Q3 | 0.35 | 0.33 | 0.55 | -0.34 | 0.39 | - | - | - | -0.35 |
| Q4 | 0.39 | 0.31 | 0.50 | -0.34 | -1.38 | -5.36 | -2.73 | -23.35 | - |
| A | 1.2 | 1.4 | 1.6 | -1.5 | -1.4 | -5.4 | -2.7 | -84.6 | -1.17 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | 70.8 | 73 | 152.7 | 160.3 | 162.6 |
| Jun | 62.3 | 71.6 | 74.5 | 154.5 | 161.2 | 163.7 |
| Sep | 69.5 | 72 | 81.2 | 159.2 | 161.7 | 165 |
| Dec | 70.1 | 72.4 | 145 | 160.1 | 161.9 | 165.6 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||
| Inventory / Stock Turnover | 13.3 | 8.9 | 6.9 | - | - | |||||
| Fixed Asset Turnover | 30.5 | 42.4 | 23.3 | 32.5 | 38 | |||||
| Total Asset Turnover | 0.6 | 0.1 | 0.1 | 0.3 | 0.3 | |||||
| Leverage | ||||||||||
| Debt Ratio | - | - | - | - | - | |||||
| Debt – Equity Ratio | - | - | - | - | - | |||||
| Interest Coverage | -1950.4 | -1.6 | 24.1 | -4.2 | -2.7 | |||||
| Equity multiplier | - | - | - | - | - | |||||